ArticleThoracic cancer2026

Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: A Single-Center Pooled Analysis.

Jialin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.